As 2022 comes to a close, it’s time to reflect on what we learned in the past year to advance our efforts into the coming year. Throughout the year, HealthCity explored many pressing issues in healthcare today: provider representation without unconsented...
The Bottom Line A new study has answered a longstanding question about whether surgical bypass or endovascular therapy is the best course of action for patients with a severe form of peripheral artery disease (PAD) known as chronic limb threatening ischemia (CLTI) or...